Reasons, Form of Ingestion and Side Effects Associated with Consumption of Amanita muscaria
- PMID: 37112610
- PMCID: PMC10142736
- DOI: 10.3390/toxics11040383
Reasons, Form of Ingestion and Side Effects Associated with Consumption of Amanita muscaria
Abstract
In recent months, there has been a new trend involving the consumption of Amanita muscaria. The aim of this article was to investigate the reasons for consumption, the form taken and the adverse symptoms that were indicated by those consuming Amanita muscaria. After analysing 5600 comments, 684 people were included in the study, who, in social media groups such as Facebook, stated the purpose of consuming the mushroom (n = 250), the form of mushroom they were taking (n = 198) or the adverse symptoms they experienced (n = 236). The gender of the subjects differentiated the parameters analysed. In the study group of women, the main purpose of consuming Amanita muscaria was to reduce pain, as well as to reduce skin problems, while in men it was mainly to relieve stress, reduce the severity of depressive symptoms and reduce insomnia (p < 0.001). With regard to the form of mushroom ingested, tincture was predominant in the women's study group, while dried was predominant in the men (p < 0.001). In terms of side effects, women reported primarily headaches, while men reported nausea, vomiting, abdominal pain and drowsiness (p < 0.001). Advanced research on Amanita muscaria should be carried out to make the community aware of the toxicity of this fungus.
Keywords: Amanita muscaria; clinical symptoms; toxicology.
Conflict of interest statement
The authors declare no conflict of interest related to this study.
Figures
Similar articles
-
Exploring User Experiences with Amanita muscaria: A Thematic Analysis of Reddit Online Forum Discussions.Subst Use Misuse. 2025;60(7):952-961. doi: 10.1080/10826084.2025.2476141. Epub 2025 Mar 8. Subst Use Misuse. 2025. PMID: 40057818
-
An Examination of Cholinergic Symptoms Produced by the Fly Agaric Mushroom Amanita muscaria (Agaricomycetes): Revisiting the Role of Muscarine.Int J Med Mushrooms. 2025;27(7):1-15. doi: 10.1615/IntJMedMushrooms.2025058603. Int J Med Mushrooms. 2025. PMID: 40228215
-
The Deceptive Mushroom: Accidental Amanita muscaria Poisoning.Eur J Case Rep Intern Med. 2021 Feb 2;8(3):002212. doi: 10.12890/2021_002212. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 33768066 Free PMC article.
-
[Amanita pantherina and Amanita muscaria poisonings--pathogenesis, symptoms and treatment].Pol Merkur Lekarski. 1997 Jul;3(13):30-2. Pol Merkur Lekarski. 1997. PMID: 9432298 Review. Polish.
-
[Poisoning with spotted and red mushrooms--pathogenesis, symptoms, treatment].Wiad Lek. 1996;49(1-6):66-71. Wiad Lek. 1996. PMID: 9173659 Review. Polish.
Cited by
-
Nature's Own Pharmacy: Mushroom-Based Chemical Scaffolds and Their Therapeutic Implications.Int J Mol Sci. 2023 Oct 26;24(21):15596. doi: 10.3390/ijms242115596. Int J Mol Sci. 2023. PMID: 37958579 Free PMC article. Review.
-
Temporal Changes in Lead and Cadmium Levels in Amanita muscaria Samples Collected in Poland.Toxics. 2025 Jan 27;13(2):101. doi: 10.3390/toxics13020101. Toxics. 2025. PMID: 39997916 Free PMC article.
-
Emerging Risks of Amanita Muscaria: Case Reports on Increasing Consumption and Health Risks.Acta Med Litu. 2025;32(1):182-189. doi: 10.15388/Amed.2025.32.1.23. Epub 2025 Feb 18. Acta Med Litu. 2025. PMID: 40641545 Free PMC article.
-
Preliminary study on the time-correlation changes in brain neurotransmitters of mice exposed to mushroom toxin ibotenic acid.Front Neurosci. 2025 Jun 2;19:1561291. doi: 10.3389/fnins.2025.1561291. eCollection 2025. Front Neurosci. 2025. PMID: 40529243 Free PMC article.
-
Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms - Charlottesville, Virginia, 2023-2024.MMWR Morb Mortal Wkly Rep. 2024 Jul 18;73(28):628-630. doi: 10.15585/mmwr.mm7328a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39024197 Free PMC article. No abstract available.
References
-
- The Council of the European Union Council Decision of 2 December 2010 on Submitting 4-Methylmethcathinone (Mephedrone) to Control Measures. Official Journal of the European Union. Dec 8, 2010. [(accessed on 9 April 2023)]. Available online: http://www.emcdda.europa.eu/attachements.cfm/att_134870_EN_Council_Decis....
-
- UK Parliament Psychoactive Substances Act 2016. Jan 29, 2016. [(accessed on 9 April 2023)]. Available online: http://services.parliament.uk/bills/2015-16/psychoactivesubstances.html.
LinkOut - more resources
Full Text Sources